• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 3. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Chemical Profile of 4-fluoro-1H-indazol-7-amine (CAS No. 866144-03-8)

4-fluoro-1H-indazol-7-amine, identified by its Chemical Abstracts Service (CAS) number 866144-03-8, is a fluorinated indazole derivative that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the broader class of heterocyclic aromatic amines, which are widely studied for their potential biological activities. The presence of a fluorine atom at the 4-position and an amine group at the 7-position introduces unique electronic and steric properties, making it a valuable scaffold for drug discovery and development.

The indazole core is a privileged structure in medicinal chemistry, known for its role in various bioactive molecules. Its fused bicyclic system, consisting of a benzene ring and a pyrazole ring, provides a versatile platform for structural modifications. The introduction of fluorine at the 4-position enhances the lipophilicity and metabolic stability of the molecule, which are critical factors in drug design. Additionally, the amine functionality at the 7-position allows for further derivatization, enabling the exploration of diverse pharmacophores.

In recent years, fluorinated indazoles have been extensively investigated due to their broad spectrum of biological activities. These compounds have shown promise in various therapeutic areas, including oncology, inflammation, and central nervous system disorders. The fluorine atom's ability to modulate pharmacokinetic properties has made it a preferred substituent in drug development. Specifically, 4-fluoro-1H-indazol-7-amine has been explored as a potential lead compound in the synthesis of novel therapeutic agents.

One of the most compelling aspects of 4-fluoro-1H-indazol-7-amine is its utility as an intermediate in the synthesis of more complex molecules. Researchers have leveraged this compound to develop novel inhibitors targeting specific enzymes and receptors involved in disease pathways. For instance, studies have demonstrated its role in generating derivatives with anti-inflammatory properties by modulating cytokine production and signaling pathways. The amine group at the 7-position has been particularly useful in forming hydrogen bonds with biological targets, enhancing binding affinity.

The pharmaceutical industry has shown increasing interest in fluorinated heterocycles due to their improved pharmacological profiles. 4-fluoro-1H-indazol-7-amine exemplifies this trend, as it combines structural features that are known to enhance drug-like properties such as solubility, bioavailability, and target interaction. Recent advancements in computational chemistry have further facilitated the design of derivatives based on this scaffold by predicting binding interactions and optimizing molecular geometry.

Moreover, synthetic methodologies for 4-fluoro-1H-indazol-7-amine have been refined to ensure high yield and purity, making it accessible for large-scale applications. Modern synthetic routes often involve multi-step processes that incorporate fluorination techniques such as electrophilic aromatic substitution or metal-catalyzed cross-coupling reactions. These methods have enabled researchers to explore structural diversity efficiently, leading to the discovery of novel analogs with enhanced biological activity.

In clinical research, 4-fluoro-1H-indazol-7-amine has been evaluated for its potential therapeutic effects in preclinical models. Studies have highlighted its role in modulating pathways associated with cancer progression by inhibiting key enzymes involved in cell proliferation and survival. The fluorine atom's electronic effects have been shown to enhance binding interactions with target proteins, leading to increased potency. Additionally, derivatives of this compound have demonstrated promising results in reducing inflammation by inhibiting pro-inflammatory cytokines.

The development of 4-fluoro-1H-indazol-7-amine derivatives continues to be an active area of research, with scientists exploring new synthetic strategies and biological applications. Advances in crystallography and spectroscopy have provided deeper insights into its molecular interactions, aiding in the rational design of next-generation drugs. The compound's versatility as a scaffold has opened doors for innovation across multiple therapeutic domains.

As our understanding of molecular mechanisms evolves, so does the potential of 4-fluoro-1H-indazol-7-amine in addressing unmet medical needs. Its unique structural features make it an attractive candidate for further exploration in drug discovery programs aimed at developing safer and more effective treatments. The ongoing research into this compound underscores its significance as a building block for innovative pharmaceutical solutions.

• 886564-22-3(2H-Indazol-7-amine, 4-fluoro-2-methyl-)
• 1360963-10-5(5-fluoro-1H-indazol-6-amine)
• 918903-47-6(2H-Indazol-7-amine)
• 21443-96-9(1H-Indazol-7-amine)
• 885520-16-1(6-Fluoro-1H-indazol-4-amine)
• 1780425-08-2(6-fluoro-1H-indazol-7-amine)
• 1352397-94-4(5-Fluoro-1H-indazol-7-amine)
• 935250-69-4(4-Fluoro-1H-indazol-5-amine)
• 885520-07-0(4-Fluoro-1H-indazol-6-amine)
• 709046-14-0(6-Fluoro-1H-indazol-5-amine)